Submission instructions - 22. ESC London 2013
Please read and follow carefully!

Abstract submission for the 22. ESC, London, UK opened!
Please follow the links using "Abstracts" above!

1. For abstract submission use the online form on our website and follow the fields carefully! It is important that you enter your current e-mail address accurately! Please inform us about any changes immediately!

2. The form fields are divided into two areas:
Submitting person (usually presenting first author!)
Abstract details:
Abstract title, max. 200 characters/signs, including blanks!
Abstract text, max. 2000 characters/signs, including blanks!
Authors: First responsible/ presenting author including e-mail address
14 co-authors maximum, sequence cannot be modified after submission; under such circumstances you may use: “… on  behalf of…” or “ …for the XX trialists…”

3. Tables (max. 12 columns/15 rows, word file, clear strutured!) and graphics/figures (jpeg, gif) are to be submitted separately after successful abstract submission via email including the AID. Maximum 2 figures (jpeg,gif) or 1 table (word file) and 1 figure, or 2 tables (word file) per abstract can be submitted via e-mail to: office@eurostroke.eu  (deadline 13 January 2013 for regular abstracts; 18 February for Nurses/AHP's, 9 May 2013 for "Ongoing Trials))!
Tables and figures are just an option and not a must!

4. Abstracts must be written in English and structured according to four categories: "Background, Methods, Results and Conclusion".
Abstracts should contain original material only, which has not been published elsewhere (for copyright reasons).  In case of doubt please contact our office@eurostroke.eu.
Abstracts received after the  deadline will not be reviewed!
Abstracts cannot be changed anymore after submission!

5. "Platform preferred" implies that your abstract will be considered for the platform programme primarily, but also for poster presentation. Platform presentations last eight minutes followed by two minutes discussion.

6. "Poster preferred" implies that your abstract will be considered for poster presentation exclusively. Posters (including e-posters) will be displayed on  two days and authors must be available for discussion during the individual poster sessions.

7. Only abstract submissions confirmed by an AID (Abstract Identification Number) will enter the review process!
You will receive your „AID“ by pressing the button   „Send“! This opens the confirmation form. Fill in the last name, password and email (submitting person) exactly as you did before in the abstract form and press again the „Send“ button!
Please make sure prior to the deadline of submission you'd received an AID for each submitted abstract. (Deadline: 13 January 2013)
If you have any questions please contact hennerici@eurostroke.eu

8. Information about the results of the review process will usually become available in early march 2013. Only the first author (presenting author) will receive an email about the acceptance of the abstract (not all authors).

9. Late deadlines (after January 13, 2013) will only be possible for "Ongoing Trials".

9 May 2013

Please download the submission instructions as  PDF  (91kb)

• 
  Tip! Please find a special article which may help! - "Writing Good Abstracts"
  
  

  Abstract submission will open by the end of October 2012
  

  
  

•  Deadlines

  • • ■ Regular abstract deadline: 13 January 2013
      ■ Nurses/AHP's abstract deadline: 18 February 2013
      ■ "Ongoing Trials"abstract deadline: 9 May 2013

 

Subject areas/Topics 2013

 

Epidemiology of stroke

Acute stroke:emergency management, stroke units and complications

Acute stroke: clinical patterns and practice

Acute stroke: current treatment

Acute stroke: new treatment concepts

Acute cerebrovascular events (ACE): TIA and minor strokes

Stroke prognosis

Stroke prevention

Interesting and challenging cases

Vascular imaging

Brain imaging

Etiology of stroke and risk factors

Rehabilitation and reorganisation after stroke

Vascular surgery and neurosurgery

Intracerebral/subarachnoid haemorrhage and venous diseases

Management and economics

Heart and brain

Behavioral disorders and post-stroke dementia

Small vessel stroke and white matter disease

Experimental studies

Vascular biology

Large clinical trials (RCTs)

Meta-analysis and reviews

Translational stroke research

Interventional neurology

Recent news in stroke research

Ongoing Trials
There will be no review process for “Ongoing Trials”which will be published immediatly after submitting online!
Only poster presentations will be accepted!

Forms

Regular Form
Ongoing Trial Form
Form for Nurses/AHP's